历时数月、备受资本市场期待的华润医药重组规划戛然而止。5月5日,华润系旗下两家医药类上市公司华润双鹤和华润三九都发布公告,称控股股东根据近期内外部情况发生的变化,正在研究资产重组计划,预计短期内不能确定资产重组方案,决定终止重组。市场普遍猜测,华润医药重组项目突然终止,是受到4月下旬华润集团董事长宋林落马事件的殃及。业内预测,在华润医药 In a few months, much expectation of the capital market Huarun pharmaceutical restructuring plan came to an abrupt end. On May 5, CRRC’s two pharmaceutical listed companies, CR Shuanghe and CRNC, both issued announcements stating that controlling shareholders are studying the asset reorganization plan in light of recent changes in internal and external conditions and are not expected to determine the reorganization of assets in the short term Program, decided to terminate the reorganization. It is generally speculated that the sudden termination of the CRP reorganization project was affected by Songlin, Chairman of China Resources Group, who fell in late April. Industry forecasting, China Resources Pharmaceuticals